In order to address the pandemic we faced, Instituto Gulbenkian de Ciência redirected its research activities and optimized its cutting-edge technological equipment to take part in the response to this new virus. IGC’s teams were mobilized to fight COVID-19 and there were several initiatives taking place at this level. The initiatives ranged from diagnostic and research to international and national cooperation with other research centers and public entities. 

SARS-CoV-2, the virus

The ability to follow and monitor the evolution of the virus, in real time, was one of the biggest competitive advantages to tackle the pandemic and the disease.

• Know more

Vaccine effectiveness study

Monitoring the vaccine’s effectiveness and impact was crucial to know the immediate and long-term effects, as many questions remained unanswered in clinical trials.

• Know more

Saliva as a diagnostic test

The use of saliva as the preferred sample in the diagnosis of SARS-CoV-2, in all group ages, determined the development of a study at IGC in collaboration with Hospital Dona Estefânia and Hospital Amadora Sintra.

• Know more